Correlation of Human Papillomavirus Type 16 and Human Papillomavirus Type 18 E7 Messenger RNA Levels with Degree of Cervical Dysplasia
Open Access
- 1 August 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (8) , 1948-1952
- https://doi.org/10.1158/1055-9965.epi-05-0073
Abstract
Infection with certain types of human papillomavirus (HPV) is a necessary event in the development of cervical carcinoma; however, not all women who become infected with HPV will progress to cancer. Much is known about the molecular influence of HPV E6 and E7 proteins on the malignant transformation. Little is known about the additional factors needed to drive the process. Quantitative real-time PCR was used to quantitate mRNA expression of the E7 gene in women exhibiting normal epithelium, low-grade squamous intraepithelial lesions (LSIL), and high-grade squamous intraepithelial lesions (HSIL). Prevalence of mRNA transcripts was lower among normal women (27%) than for women with LSIL (40%) and HSIL (37%). Mean levels ranged from 2.0 (ln scale per 20 ng cDNA) among normal women to 4.2 among those with HSIL, with a significant trend (P = 0.008). This trend was only significant for HPV 18 transcripts if separately analyzed by HPV type. The transcriptional activity of HPV 18 is higher than that of HPV 16 and increases with increasing level of dysplasia. This is in concert with the findings of other studies, and reinforces the notion that HPV 18 is a more aggressive viral type. Real-time PCR of viral transcripts could provide a more efficient method to analyze the oncogenic potential within cells from a cervical swab, thus providing a way to better screen women who may progress to higher grade lesions or invasive carcinoma from those who will spontaneously regress.Keywords
This publication has 14 references indexed in Scilit:
- Human papillomavirus type specific DNA and RNA persistence—implications for cervical disease progression and monitoringJournal of Medical Virology, 2004
- Human papillomavirus integration: detection by in situ hybridization and potential clinical applicationThe Journal of Pathology, 2003
- Measurements of Human Papillomavirus Transcripts by Real Time Quantitative Reverse Transcription-Polymerase Chain Reaction in Samples Collected for Cervical Cancer ScreeningThe Journal of Molecular Diagnostics, 2002
- Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real‐time polymerase chain reaction analysisCancer, 2002
- Human Papillomavirus Types 16 E6 and E7 Contribute Differently to CarcinogenesisVirology, 2000
- Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines☆☆Supported by NIH grants R29 CA72427 (Z.C.), R55 DE OD10846 (K.A-S.), and P50DE11906 (K.A-S. and G.L.C.).Oral Oncology, 1999
- Absence of human papillomavirus type 16 E6 transcripts in HPV 16‐infected, cytologically normal cervical scrapingsJournal of Medical Virology, 1993
- Natural History of Cervical Intraepithelial NeoplasiaInternational Journal of Gynecological Pathology, 1993
- Characterization of HPV-16 E6E7 transcription in CaSki cells by quantitative PCRMolecular and Cellular Probes, 1992
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990